Is Biomerica, Inc. (BMRA) a Buy, Sell, or Hold?
NASDAQ : BMRA
Biomerica, Inc.
$1.6139 USD
-$0.02 (-0.99%)
- Volume
- 3.96K
- Average Volume
- 17.01K
- Market Capitalization
- $4.99M
- P/E Ratio
- -1.54
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $4.60
- Year Low
- $1.61
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.64
| Source | Headline |
|---|---|
|
Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
Auto-renewing Master Services Agreement engages Biomerica's integrated development and manufacturing platform, reflecting the Company's CDMO strategy as a capital-efficient, parallel revenue stream alongside its core inFoods® IBS program Auto-renewing Master Services Agreement engages Biomerica's integrated development and manufacturing platform, reflecting the Company's CDMO strategy as a capital-efficient, parallel revenue stream alongside its core inFoods® IBS program globenewswire.com - 2026-05-28 08:19:00 |
|
Biomerica's inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026
Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world's largest GI medical conference, May 2–5, 2026, in Chicago Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world's largest GI medical conference, May 2–5, 2026, in Chicago globenewswire.com - 2026-04-29 08:19:00 |
